NEW DRUG SCREENING METHOD FOR THE TREATMENT OF BRAIN METASTASES

Brain metastases are an unmet clinical need that currently affects up to 25% of cancer patients, but current available therapies have limited efficacy and fail to improve survival. To address this situation, the team led by Manuel Valiente, head of the Brain Metastasis Group at the Spanish National Cancer Research Center (CNIO), has designed the …

NEW DRUG SCREENING METHOD FOR THE TREATMENT OF BRAIN METASTASES Read More »